THERAZONE ApS: Financial statements 2015
CVR: 27255574
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
THERAZONE ApS (CVR 27255574) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 24,614 and a net result of DKK 484,500 compared with DKK 509,134 the year before. That is a decrease of 2.9% compared with the year before. Equity in the 2015 report amounted to DKK 890,240. The solvency ratio was 48.4%.
- Gross Profit
- DKK 24,614
- Profit/Loss
- DKK 484,500
- Equity
- DKK 890,240
- Total Assets
- DKK 1,837,470
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 25 t. | 485 t. | 890 t. | - |
| 2014 | - | 25 t. | 509 t. | 406 t. | - |
| 2013 | - | -1 t. | -234 t. | -103 t. | - |
| 2012 | - | -12 t. | 193 t. | 131 t. | - |
Official annual report
How creditworthy is THERAZONE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
THERAZONE ApS has published its annual report for 2014. Gross profit came to DKK 25,362, and the net result was DKK 509,134.
About THERAZONE ApS
THERAZONE ApS is a Danish company of the type Anpartsselskab based in Dragør, founded in 2003. The company is registered under the industry Investering for egen regning. The management consists of Thomas Magnussen. The company is owned by Thomas Magnussen. The company has 2 employees (2026). In 2024, the company reported a gross profit of DKK -255,949 and a net result of DKK 4,003,809 compared with DKK 2,462,806 the year before. Equity in the 2024 report amounted to DKK 44,842,105.